- Home
- MIST vs SBFM Comparison
MIST vs SBFM Comparison
Compare MIST & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- SBFM
- Stock Information
- Founded
- MIST 2003
- SBFM 2006
- Country
- MIST Canada
- SBFM United States
- Employees
- MIST N/A
- SBFM N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- MIST Health Care
- SBFM Health Care
- Exchange
- MIST Nasdaq
- SBFM Nasdaq
- Market Cap
- MIST 53.9M
- SBFM 4.9M
- IPO Year
- MIST N/A
- SBFM N/A
- Fundamental
- Price
- MIST $1.11
- SBFM $1.25
- Analyst Decision
- MIST Strong Buy
- SBFM Strong Buy
- Analyst Count
- MIST 2
- SBFM 1
- Target Price
- MIST $9.50
- SBFM $15.00
- AVG Volume (30 Days)
- MIST 1.6M
- SBFM 788.6K
- Earning Date
- MIST 05-20-2025
- SBFM 05-19-2025
- Dividend Yield
- MIST N/A
- SBFM N/A
- EPS Growth
- MIST N/A
- SBFM N/A
- EPS
- MIST N/A
- SBFM N/A
- Revenue
- MIST N/A
- SBFM $34,874,283.00
- Revenue This Year
- MIST N/A
- SBFM $192.48
- Revenue Next Year
- MIST N/A
- SBFM N/A
- P/E Ratio
- MIST N/A
- SBFM N/A
- Revenue Growth
- MIST N/A
- SBFM 44.75
- 52 Week Low
- MIST $0.63
- SBFM $1.17
- 52 Week High
- MIST $2.75
- SBFM $23.20
- Technical
- Relative Strength Index (RSI)
- MIST 43.96
- SBFM 36.33
- Support Level
- MIST $1.28
- SBFM $1.24
- Resistance Level
- MIST $1.32
- SBFM $1.45
- Average True Range (ATR)
- MIST 0.12
- SBFM 0.12
- MACD
- MIST 0.02
- SBFM 0.01
- Stochastic Oscillator
- MIST 27.39
- SBFM 10.26
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.